Waiting . . . And Waiting

Markets are still moving higher, against my expectations for the summer. I have mixed feelings about that. On the one hand, I’m happy that I didn’t short anything and that my remaining positions are rising. On the other, I wish I hadn’t sold anything earlier. All in all, though, we’re not in too bad of shape. The techniques I write about in my books and here, particularly entering and exiting positions gradually, have worked well.

Here are the bullish factors:

– The Fed tightening cycle is expected to end.
– China will now value the Yuan against a basket of currencies instead of pegging it to the dollar. That’s good for global pricing balance.
– Oil prices have not gone to the moon.

I’ve thought from the beginning of the year that clearing August would put us in good position for a second half run to higher ground. So far, though, we haven’t had the cheaper prices that I expected to presage that move higher. I’m still holding off, as we’re not out of summer yet, but if markets never do see lower prices I may end up buying into a cycle that’s already underway. That’s not my usual approach — I generally buy at the bottom when everybody loathes stocks — but momentum can also work.

Too, my old standby tech trade, Sun, has not risen much in this summer happiness. It closed last week at $3.88, still below the $4 demarcation line I mentioned in several previous posts. If we get even a small settling back in August, there could be a chance to get into Sun at $3.50 for a fall/winter run to $5.50.

Let’s not forget Pfizer. That stock is still cheap. If you’re looking for a dollar-cost averaging target that keeps fluctuating in a low range but has every demographic tally in its favor, Pfizer’s your baby. It hasn’t been able to find traction for the past couple of years, but could well be a double from $25. Buying anywhere in its recent price range should prove profitable in the next few years.

I’m looking at several other potential investments. The overarching theme is that I’m waiting for the right prices and am surprised that they haven’t become available yet.

This entry was posted in Uncategorized. Bookmark the permalink. Both comments and trackbacks are currently closed.
  • The Kelly Letter
    A Complete Investment Management System
    The Kelly Letter  every Sunday morning by email.
    Like no other. Many subscribers say this is the best read of their week, astonishing in its ability to distill seven days of noise into one succinct overview of the very few items that might matter. Start your Sundays right!
    A one-page Quick Start Guide
    with page number references to full information in The 3% Signal. You'll receive access to this right away so you can begin transforming your portfolio into a performance machine immediately.
    The 3Sig Calculator.
    A thing of beauty! You'll use it to generate your own personal signals every quarter including exact share amounts to buy and sell based on your account balances. It emails you the results to make later quarters easy by keeping last quarter's numbers at your fingertips. Some subscribers say this tool alone justifies their subscription price.
    The subscriber-only section of this website
    where likeminded investors are commenting on notes and discussing in forums. Jason joins these interactions every day. They're a treasure trove of investing tips and wisdom.
    The archive of Kelly Letter notes.
    It’s a research center, searchable and smartly tagged to make gathering time-stamped material on covered subjects easy.
    The subscriber podcast.
    Jason reads every letter word-for-word. This feature was requested by subscribers who prefer audio learning. They listen on their Monday morning commute, during a workout, or while reading along at their computer.



    $200/year
    Save 17%



    $20/month
    Pay as you go
    Or sign up to receive free email and learn more about the system.
    Do you have a question?
Bestselling Financial Author